Esperion Therapeutics Secures $33,000,000 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=54581888-5aa9-4d47-8760-c047575de9e7&Preview=1 - Date
4/25/2013 - Company Name
Esperion Therapeutics - Mailing Address
46701 Commerce Center Drive Plymouth, MI 48170 - Company Description
Esperion Therapeutics, Inc. discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a novel class of drugs that focuses on a new treatment approach called HDL Therapy, which is based on the Company’s understanding of high-density lipoprotein, or HDL, function. - Website
http://www.esperion.com - Transaction Type
Venture Equity - Transaction Amount
$33,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
We intend to use this financing to advance ETC-1002 through the next important phase of development. - M&A Terms
- Venture Investor
Longitude Capital Management - Venture Investor
Aisling Capital - Venture Investor
Alta Partners - Venture Investor
Domain Associates - Venture Investor
Asset Management Company - Venture Investor
Arboretum Ventures
